BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 27613370)

  • 21. Efficacy of the Motivational Interviewing-Walk Intervention for Chemotherapy-Induced Peripheral Neuropathy and Quality of Life During Oxaliplatin Treatment: A Pilot Randomized Controlled Trial.
    Kanzawa-Lee GA; Ploutz-Snyder RJ; Larson JL; Krauss JC; Resnicow K; Lavoie Smith EM
    Cancer Nurs; 2022 Mar-Apr 01; 45(2):E531-E544. PubMed ID: 34483279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer.
    Argyriou AA; Cavaletti G; Briani C; Velasco R; Bruna J; Campagnolo M; Alberti P; Bergamo F; Cortinovis D; Cazzaniga M; Santos C; Papadimitriou K; Kalofonos HP
    Cancer; 2013 Jan; 119(2):438-44. PubMed ID: 22786764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of Chronic Oxaliplatin-Induced Hypesthesia in Two Areas of the Hand.
    Andriamamonjy M; Delmotte JB; Savinelli F; Beaussier H; Coudoré F
    J Clin Neurophysiol; 2017 Mar; 34(2):126-131. PubMed ID: 27749615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study.
    Tsuruta A; Yamashita K; Tanioka H; Tsuji A; Inukai M; Yamakawa T; Yamatsuji T; Yoshimitsu M; Toyota K; Yamano T; Nagasaka T; Okajima M
    Drug Des Devel Ther; 2016; 10():3827-3835. PubMed ID: 27920498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with the development and severity of oxaliplatin-induced peripheral neuropathy: a systematic review.
    Pulvers JN; Marx G
    Asia Pac J Clin Oncol; 2017 Dec; 13(6):345-355. PubMed ID: 28653815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute oxaliplatin-induced peripheral nerve hyperexcitability.
    Wilson RH; Lehky T; Thomas RR; Quinn MG; Floeter MK; Grem JL
    J Clin Oncol; 2002 Apr; 20(7):1767-74. PubMed ID: 11919233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial.
    Lu W; Giobbie-Hurder A; Freedman RA; Shin IH; Lin NU; Partridge AH; Rosenthal DS; Ligibel JA
    Oncologist; 2020 Apr; 25(4):310-318. PubMed ID: 32297442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase 2 Study of Acupuncture-Like Transcutaneous Nerve Stimulation for Chemotherapy-Induced Peripheral Neuropathy.
    Wong R; Major P; Sagar S
    Integr Cancer Ther; 2016 Jun; 15(2):153-64. PubMed ID: 27130723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reflexology in the management of chemotherapy induced peripheral neuropathy: A pilot randomized controlled trial.
    Kurt S; Can G
    Eur J Oncol Nurs; 2018 Feb; 32():12-19. PubMed ID: 29353627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxaliplatin-induced neuropathy in colorectal cancer: many questions with few answers.
    Zedan AH; Hansen TF; Fex Svenningsen A; Vilholm OJ
    Clin Colorectal Cancer; 2014 Jun; 13(2):73-80. PubMed ID: 24365057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy.
    Chen SJ; Chen LH; Yeh YM; Lin CK; Lin PC; Huang HW; Shen MR; Lin BW; Lee JC; Lee CC; Lee YF; Chiang HC; Chang JY
    Theranostics; 2021; 11(10):4672-4687. PubMed ID: 33754020
    [No Abstract]   [Full Text] [Related]  

  • 32. The efficacy and safety of electro-acupuncture for alleviating chemotherapy-induced peripheral neuropathy in patients with coloreactal cancer: study protocol for a single-blinded, randomized sham-controlled trial.
    Chan K; Lui L; Yu K; Lau K; Lai M; Lau W; Ng B; Zhong LLD; Bian ZX
    Trials; 2020 Jan; 21(1):58. PubMed ID: 31918748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Randomized Assessor-Blinded Wait-List-Controlled Trial to Assess the Effectiveness of Acupuncture in the Management of Chemotherapy-Induced Peripheral Neuropathy.
    Molassiotis A; Suen LKP; Cheng HL; Mok TSK; Lee SCY; Wang CH; Lee P; Leung H; Chan V; Lau TKH; Yeo W
    Integr Cancer Ther; 2019; 18():1534735419836501. PubMed ID: 30905173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The preventive effect of sensorimotor- and vibration exercises on the onset of Oxaliplatin- or vinca-alkaloid induced peripheral neuropathies - STOP.
    Streckmann F; Balke M; Lehmann HC; Rustler V; Koliamitra C; Elter T; Hallek M; Leitzmann M; Steinmetz T; Heinen P; Baumann FT; Bloch W
    BMC Cancer; 2018 Jan; 18(1):62. PubMed ID: 29316888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of acute and chronic neuropathies induced by oxaliplatin in mice and differential effects of a novel mitochondria-targeted antioxidant on the neuropathies.
    Toyama S; Shimoyama N; Ishida Y; Koyasu T; Szeto HH; Shimoyama M
    Anesthesiology; 2014 Feb; 120(2):459-73. PubMed ID: 24064792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of delayed oxaliplatin-induced pseudo-obstruction: an atypical presentation of oxaliplatin neurotoxicity.
    Vandamme M; Pauwels W; Bleecker JD
    Acta Clin Belg; 2015 Jun; 70(3):207-10. PubMed ID: 25523317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents.
    Ushio S; Egashira N; Sada H; Kawashiri T; Shirahama M; Masuguchi K; Oishi R
    Eur J Cancer; 2012 Jun; 48(9):1407-13. PubMed ID: 21907570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral neuropathy in colorectal cancer survivors: the influence of oxaliplatin administration. Results from the population-based PROFILES registry.
    Beijers AJ; Mols F; Tjan-Heijnen VC; Faber CG; van de Poll-Franse LV; Vreugdenhil G
    Acta Oncol; 2015 Apr; 54(4):463-9. PubMed ID: 25417732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late effects of oxaliplatin-induced peripheral neuropathy (LEON)--cross-sectional cohort study of patients with colorectal cancer surviving at least 2 years.
    Padman S; Lee J; Kumar R; Slee M; Hakendorf P; Richards A; Koczwara B; Kichenadasse G; Sukumaran S; Roy A; Vatandoust S; Karapetis CS
    Support Care Cancer; 2015 Mar; 23(3):861-9. PubMed ID: 25223350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral neuropathy in patients with colorectal cancer receiving oxaliplatin.
    Tofthagen C; McAllister RD; McMillan SC
    Clin J Oncol Nurs; 2011 Apr; 15(2):182-8. PubMed ID: 21444285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.